2026
RESI JPM（Redefining Early Stage Investments – JPM Week）是全球醫療創新與投資界矚目的年度盛會，匯聚了來自世界各地的早期生技企業、投資人與業界領袖。
其Innovator's Pitch Challeng是此次大會的重要亮點之一，為早期創新公司提供一個絕佳舞台，可向全球投資者展示技術亮點與商業潛力，並於互動問答與評審實時交流中獲得寶貴回饋。
在為期兩天的挑戰中，VerImmune 在 24 個領域細分的 Pitch Session 中，以六分鐘簡報與七分鐘 Q&A 的形式向資深投資評審團展現公司核心技術與願景。
最終，依據現場投資人與與會者以 RESI Cash 投票結果，以及評審團綜合評估，VerImmune 成功奪下第二名的優異成績。
這項肯定不僅代表 VerImmune 在技術與市場前景上獲得國際投資圈的認可，也彰顯了公司團隊在生醫創新路上的堅定實力與卓越表現。
VerImmune 將持續推動其在免疫學領域的突破性研發，並與全球合作夥伴深化交流與合作，共同邁向更具影響力的下一階段。
In compliance with EU personal data protection laws, we are committed to protecting and providing you with control over your personal data. By clicking "Accept All", you allow us to place cookies to enhance your experience on this site, help us analyze site performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. By clicking "Agree" you agree to the current settings. For more information, please visit the Privacy Statement.
This website uses cookies
In compliance with EU personal data protection laws, we are committed to protecting your personal data and providing you with control over it. By clicking "Agree", you allow us to place cookies to improve your experience on this site, help us analyze site performance and usage, and allow us to deliver relevant marketing content.
By clicking "Only necessary" you allow us to place only necessary cookies. The website cannot function without these cookies and you cannot switch them off on your system. These cookies are typically set only in response to an action you perform (i.e. a service request), such as setting privacy preferences, logging in, or filling in a form. You can set your browser to block or prompt you for these cookies, but this may prevent some site features from working.
